2022
Early Release - Economic Burden of Reported Lyme Disease in High-Incidence Areas, United States, 2014–2016 - Volume 28, Number 6—June 2022 - Emerging Infectious Diseases journal - CDC
Hook S, Jeon S, Niesobecki S, Hansen A, Meek J, Bjork J, Dorr F, Rutz H, Feldman K, White J, Backenson P, Shankar M, Meltzer M, Hinckley A. Early Release - Economic Burden of Reported Lyme Disease in High-Incidence Areas, United States, 2014–2016 - Volume 28, Number 6—June 2022 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2022, 28: 1170-1179. PMID: 35608612, PMCID: PMC9155891, DOI: 10.3201/eid2806.211335.Peer-Reviewed Original ResearchConceptsTotal societal costsSocietal costsLyme diseasePatient costsInfectious Diseases journal - CDCMean patient costMean societal costLyme disease endemic stateTotal patient costsCost-effectiveness analysisDisseminated diseaseProspective studyEarly diagnosisIncidence areaDiseaseEffective preventionProbable diseaseDemographic factorsPrevention methodsComprehensive economic evaluationEconomic evaluationPatientsVaccineIllnessDiagnosis
2021
Evaluating public acceptability of a potential Lyme disease vaccine using a population-based, cross-sectional survey in high incidence areas of the United States
Hook SA, Hansen AP, Niesobecki SA, Meek JI, Bjork JKH, Kough EM, Peterson MS, Schiffman EK, Rutz HJ, Rowe AJ, White JL, Peel JL, Biggerstaff BJ, Hinckley AF. Evaluating public acceptability of a potential Lyme disease vaccine using a population-based, cross-sectional survey in high incidence areas of the United States. Vaccine 2021, 40: 298-305. PMID: 34895785, DOI: 10.1016/j.vaccine.2021.11.065.Peer-Reviewed Original ResearchConceptsLyme disease vaccineDisease vaccineSurvey-weighted descriptive statisticsMultivariable multinomial logistic regression modelsCross-sectional studyLyme disease incidenceHigh incidence areaCross-sectional surveyLogistic regression modelsSafety concernsMultinomial logistic regression modelsVaccine uptakeAdults 45Vaccine parametersVaccine candidatesVaccine attitudesPrevention optionsHealthcare providersWeb-based surveyVaccineSociodemographic characteristicsIncidence areaLyme diseaseDisease incidenceIncidenceHuman‐tick encounters as a measure of tickborne disease risk in lyme disease endemic areas
Hook S, Nawrocki C, Meek J, Feldman K, White J, Connally N, Hinckley A. Human‐tick encounters as a measure of tickborne disease risk in lyme disease endemic areas. Zoonoses And Public Health 2021, 68: 384-392. PMID: 33554467, PMCID: PMC10883354, DOI: 10.1111/zph.12810.Peer-Reviewed Original Research
2015
Testing practices and volume of non-Lyme tickborne diseases in the United States
Connally N, Hinckley A, Feldman K, Kemperman M, Neitzel D, Wee S, White J, Mead P, Meek J. Testing practices and volume of non-Lyme tickborne diseases in the United States. Ticks And Tick-borne Diseases 2015, 7: 193-198. PMID: 26565931, PMCID: PMC4659751, DOI: 10.1016/j.ttbdis.2015.10.005.Peer-Reviewed Original Research
2014
Lyme Disease Testing by Large Commercial Laboratories in the United States
Hinckley A, Connally N, Meek J, Johnson B, Kemperman M, Feldman K, White J, Mead P. Lyme Disease Testing by Large Commercial Laboratories in the United States. Clinical Infectious Diseases 2014, 59: 676-681. PMID: 24879782, PMCID: PMC4646413, DOI: 10.1093/cid/ciu397.Peer-Reviewed Original ResearchConceptsNumber of infectionsLarge commercial laboratoriesSource patientsLyme diseaseLyme disease testingFrequency of infectionTotal direct costsTwo-tiered testingCommercial laboratoriesPositive testPatientsDisease testingDiagnostic recommendationsVolume of testingLD testingInfectionDirect costsExposure historyLD testLaboratory resultsLaboratory testingUnited StatesAlternative testingTotal number
2009
Peridomestic Lyme Disease Prevention Results of a Population-Based Case–Control Study
Connally NP, Durante AJ, Yousey-Hindes KM, Meek JI, Nelson RS, Heimer R. Peridomestic Lyme Disease Prevention Results of a Population-Based Case–Control Study. American Journal Of Preventive Medicine 2009, 37: 201-206. PMID: 19595558, DOI: 10.1016/j.amepre.2009.04.026.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAnimalsCase-Control StudiesChildChild, PreschoolConnecticutEnvironment DesignEnvironmental ExposureFemaleHumansHygieneInfantLogistic ModelsLyme DiseaseMaleMatched-Pair AnalysisMiddle AgedPopulation SurveillanceProspective StudiesResidence CharacteristicsRisk FactorsSurveys and QuestionnairesTicksYoung AdultConceptsCase-control studyLyme diseaseDisease prevention initiativesConditional logistic regressionDisease prevention measuresErythema migransPotential confoundersRecreational exposureLogistic regressionProspective ageDiseaseCase onsetPrevention resultsPrevention measuresPersonal protectionRiskHoursConfoundersMigransTicksInfectionStudyConnecticut communitiesMonths
2000
The Emergence of Another Tickborne Infection in the 12-Town Area around Lyme, Connecticut: Human Granulocytic Ehrlichiosis
IJdo J, Meek J, Cartter M, Magnarelli L, Wu C, Tenuta S, Fikrig E, Ryder R. The Emergence of Another Tickborne Infection in the 12-Town Area around Lyme, Connecticut: Human Granulocytic Ehrlichiosis. The Journal Of Infectious Diseases 2000, 181: 1388-1393. PMID: 10751139, DOI: 10.1086/315389.Peer-Reviewed Original ResearchConceptsHuman granulocytic ehrlichiosisTickborne infectionProspective population-based surveillanceGranulocytic ehrlichiosisCommon tickborne infectionPopulation-based surveillancePrimary care providersSubset of seraIndirect fluorescent antibody methodIllness suggestiveCare providersLaboratory evidenceImportant causeProbable casesFluorescent antibody methodImmunoblot assayLyme diseaseInfectionAntibody methodIncidenceEhrlichiosisLymeMorbidityDiseaseSuggestive
1996
Underreporting of Lyme Disease by Connecticut Physicians, 1992
Meek J, Roberts C, Smith E, Cartter M. Underreporting of Lyme Disease by Connecticut Physicians, 1992. Journal Of Public Health Management And Practice 1996, 2: 61-65. PMID: 10186700, DOI: 10.1097/00124784-199623000-00017.Peer-Reviewed Original Research